All times are listed in CEST (Central European Summer Time)

 

Browsing Over 476 Presentations

Sort By
Controversy session

No

Lecture Time
08:45 - 09:05
Speakers
  • A. Curioni-Fontecedro (Fribourg, Switzerland)
Session Name
Adjuvant chemotherapy in EGFR mutated NSCLC (ID 14)
Room
Auditorium 2
Date
Fri, 31.03.2023
Time
08:15 - 09:15
Authors
  • A. Curioni-Fontecedro (Fribourg, Switzerland)
Controversy session

Second vote and conclusions

Lecture Time
09:05 - 09:15
Speakers
  • L. Mezquita (Barcelona, Spain)
Session Name
Adjuvant chemotherapy in EGFR mutated NSCLC (ID 14)
Room
Auditorium 2
Date
Fri, 31.03.2023
Time
08:15 - 09:15
Authors
  • L. Mezquita (Barcelona, Spain)
Controversy session

Introduction and first vote

Lecture Time
08:15 - 08:25
Speakers
  • L. Mezquita (Barcelona, Spain)
Session Name
Adjuvant chemotherapy in EGFR mutated NSCLC (ID 14)
Room
Auditorium 2
Date
Fri, 31.03.2023
Time
08:15 - 09:15
Authors
  • L. Mezquita (Barcelona, Spain)
Controversy session

Yes

Lecture Time
08:25 - 08:45
Speakers
  • B. Besse (Villejuif, France)
Session Name
Adjuvant chemotherapy in EGFR mutated NSCLC (ID 14)
Room
Auditorium 2
Date
Fri, 31.03.2023
Time
08:15 - 09:15
Authors
  • B. Besse (Villejuif, France)
Keynote lecture

Introduction by the Chairs

Lecture Time
14:30 - 14:35
Speakers
  • N. Reguart Aransay (Barcelona, Spain)
Session Name
Air pollution and lung cancer (ID 3)
Room
Auditorium 1
Date
Fri, 31.03.2023
Time
14:30 - 15:00
Authors
  • N. Reguart Aransay (Barcelona, Spain)
Keynote lecture

Air pollution and lung cancer

Lecture Time
14:35 - 15:00
Speakers
  • C. Swanton (London, United Kingdom)
Session Name
Air pollution and lung cancer (ID 3)
Room
Auditorium 1
Date
Fri, 31.03.2023
Time
14:30 - 15:00
Authors
  • C. Swanton (London, United Kingdom)
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7) Industry Satellite Symposium

Therapeutic targets for the treatment of lung cancer

Lecture Time
13:30 - 13:40
Speakers
  • S. Popat (London, United Kingdom)
Authors
  • S. Popat (London, United Kingdom)
Session Name
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7)
Date
Thu, 30.03.2023
Time
13:30 - 15:00
Room
Auditorium 4
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7) Industry Satellite Symposium

Improving patient outcomes in KRAS G12C mutant NSCLC

Lecture Time
13:40 - 14:10
Speakers
  • H. Lena (Rennes, France)
Authors
  • H. Lena (Rennes, France)
Session Name
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7)
Date
Thu, 30.03.2023
Time
13:30 - 15:00
Room
Auditorium 4
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7) Industry Satellite Symposium

New therapeutic targets for advanced squamous NSCLC

Lecture Time
14:10 - 14:20
Speakers
  • S. Popat (London, United Kingdom)
Authors
  • S. Popat (London, United Kingdom)
Session Name
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7)
Date
Thu, 30.03.2023
Time
13:30 - 15:00
Room
Auditorium 4
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7) Industry Satellite Symposium

Targeting DLL3 with T cell engaging therapies in SCLC

Lecture Time
14:20 - 14:40
Speakers
  • A. C. Dingemans (Rotterdam, Netherlands)
Authors
  • A. C. Dingemans (Rotterdam, Netherlands)
Session Name
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7)
Date
Thu, 30.03.2023
Time
13:30 - 15:00
Room
Auditorium 4
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7) Industry Satellite Symposium

Panel discussion and Q&A

Lecture Time
14:40 - 14:55
Speakers
  • S. Popat (London, United Kingdom)
Authors
  • S. Popat (London, United Kingdom)
Session Name
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7)
Date
Thu, 30.03.2023
Time
13:30 - 15:00
Room
Auditorium 4
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7) Industry Satellite Symposium

Summary and close

Lecture Time
14:55 - 15:00
Speakers
  • S. Popat (London, United Kingdom)
Authors
  • S. Popat (London, United Kingdom)
Session Name
Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 7)
Date
Thu, 30.03.2023
Time
13:30 - 15:00
Room
Auditorium 4